Latest Articles

Publication Date
All News Scientific
Woman with fibroid the size of a large mango felt forced to go private due to NHS waiting list - AOL.com

Woman with fibroid the size of a large mango felt forced to go private due to NHS waiting list AOL.com

Published: July 26, 2026, 1:47 p.m.
Read Full Article
UDA concedes defeat in Ol Kalou by-election, says party remains strong in Mt Kenya - Citizen Digital

UDA concedes defeat in Ol Kalou by-election, says party remains strong in Mt Kenya Citizen Digital

Published: July 17, 2026, 1:56 p.m.
Read Full Article
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm

Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm

Published: July 16, 2026, 10:27 a.m.
Read Full Article
Leven Rambin reveals life-threatening surgery complication after endometriosis procedure - MSN

Leven Rambin reveals life-threatening surgery complication after endometriosis procedure MSN

Published: July 15, 2026, 9:13 p.m.
Read Full Article
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Benzinga

Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Benzinga

Published: July 15, 2026, 5:25 p.m.
Read Full Article
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ - Cleveland.com

TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ Cleveland.com

Published: July 15, 2026, 3:58 p.m.
Read Full Article
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ - OregonLive.com

TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ OregonLive.com

Published: July 15, 2026, 3:58 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace

Published: July 15, 2026, 3:11 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - Business Wire

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy Business Wire

Published: July 15, 2026, 10:45 a.m.
Read Full Article
Leven Rambin Reveals Life-Threatening Surgery Complication After Endometriosis Procedure - Yahoo

Leven Rambin Reveals Life-Threatening Surgery Complication After Endometriosis Procedure Yahoo

Published: July 11, 2026, 8:23 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!